COVID-19与临床流行病学的未来
本文为评论文章,回顾临床流行病学50年来从医生主导的临床研究转向大型队列、试验与指南的历程,讨论COVID-19大流行对临床决策与研究的挑战,以及大流行期间临床医生与研究者协作应对疾病风险、预防、预后与治疗问题的经验,提出需时间检验此经历能否复兴临床流行病学的原始实践。
要点
- COVID-19大流行促使临床医生与研究者协作,共同应对疾病风险、预防、预后与治疗决策。
- 临床流行病学50年来从医生主导的临床研究转向大型队列、试验、NIH资助与实践指南。
- 大流行期间对稀缺资源分配、临床综合征认识快速演变与广泛不确定性的共识推动了协作。
核心结论
- 需时间检验COVID-19经历能否复兴临床流行病学作为直接诊疗医生应用流行病学与生物统计方法改进健康的原始实践。
研究设计与样本
- 本文为评论文章,回顾临床流行病学过去50年的演变并讨论COVID-19大流行带来的挑战与协作经验。
主要发现
- 临床流行病学过去50年从医生主导的临床研究转向大型队列与试验、NIH资助与实践指南。
- COVID-19大流行给需紧急决策的临床医生和需理解临床综合征与关键问题的研究者带来重大挑战。
- 应对挑战促使临床医生与研究者协作,部分源于稀缺资源分配需求、临床综合征认识快速演变、广泛不确定性及共同利益优先。
关键数值与推荐
- 原文引用临床流行病学定义为直接提供患者诊疗的医生应用流行病学与生物统计方法研究诊断与治疗过程以改善健康。
临床怎么用
- 临床医生与研究者应协作应对疾病风险、预防、预后与治疗决策,尤其在资源稀缺与不确定性高的情况下。
局限性
- 本文为评论文章,未报告原始研究数据、样本量、效应值或统计检验结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical epidemiology, the "basic science for clinical medicine"[1], has changed substantially over the last 50 years, moving its focus from clinician driven research and clinical settings to large cohorts and trials, NIH funding, and practice guidelines. The COVID-19 pandemic created major challenges for clinicians who needed to make urgent decisions about the management a new disease and for researchers who needed to understand the clinical syndrome and the questions of greatest importance to the pandemic response. Addressing these challenges reunited clinicians and researchers in collaborative efforts to inform decisions about disease risk, prevention, prognosis and treatment, at least in part because of the shared sense of the need to ration scarce resources, the rapid evolution of understanding of the clinical syndrome, the recognition of widespread uncertainty, and the emphasis on the common good over individual credit. Only time will tell whether the experience during COVID-19 will revive the original practice of clinical epidemiology as "the application by a physician who provides direct patient care, of epidemiologic and biometric methods to the study of diagnostic and therapeutic process in order to effect an improvement in health"[2].
引用
- Armstrong K, Horwitz R. COVID-19 and the future of clinical epidemiology. J Clin Epidemiol. 2021. PMID: 34284101. doi:10.1016/j.jclinepi.2021.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。